Literature DB >> 20844991

Syndromic management of common illnesses in hospitalized children and neonates: a cost identification study.

Subhashchandra Daga1, Bela Verma, Satish Shahane, Sunil Janged, M Mani Vachagan.   

Abstract

OBJECTIVE: To find out drug treatment cost per illness per patient admitted to pediatric ward.
METHODS: Patients admitted to pediatric ward over a period of 1 year were studied without exclusions. Following presentations were studied: fever, rapid breathing, diarrhea, severe malnutrition and neurological problems such as altered conscious level or convulsion. In this prospective observational study, patients with other problems were excluded. The subjects were also categorized as critically sick, sick and stable. Expenditure on medicines was calculated individually for each patient. Total expenditure, average cost and illness-wise cost were subsequently derived. Management of illnesses was on the lines of existing guidelines of our center. Sick newborns or newborns referred for special care were separately studied. Following outcome variables were studied: death or discharge, length of hospital stay and the day on which symptomatic relief was noted.
RESULTS: 774 children and 141 newborns were studied. 25(3.2%) died. Presenting features were as follows: fever-568 (73.4%), rapid breathing-175 (22.6%), diarrhea-145 (18.7%), mild-moderate malnutrition-278 (35.8%), severe malnutrition-111 (14.3%) and neurological problems-41 (5.3%). Category-wise distribution was as follows: critically sick-89 (11.3%), sick-188 (24.3%) and stable-497 (46.2%). Average hospital stay was 7.1 days and symptomatic relief was experienced by day three in 77.7% cases. Average cost of medicines per patient was INR-167.8 (USD-4.2), 173 patients required oxygen and mean expenditure on oxygen was INR-310 (USD-8) and 68 patients required inotropes with a mean expenditure of INR-198 (USD-5). Of the 141 newborns admitted, 20(14.1%) died. Mean hospital stay was 9.8 days and average cost of drug treatment was INR-790 (USD-20) in newborns.
CONCLUSIONS: This cost analysis study presents drug treatment costs for common illnesses at a referral centre in a developing country. It gives an option to choose drugs for an optimum mix of cost and effectiveness.

Entities:  

Mesh:

Year:  2010        PMID: 20844991     DOI: 10.1007/s12098-010-0172-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  5 in total

1.  Introduction to health economics for physicians.

Authors:  M I Meltzer
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

2.  Drug treatment costs: projected impact of using the integrated management of childhood illnesses.

Authors:  R D Wammanda; C L Ejembi; T Iorliam
Journal:  Trop Doct       Date:  2003-04       Impact factor: 0.731

Review 3.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

4.  Health systems research in a low-income country: easier said than done.

Authors:  Mike English; Grace Irimu; Annah Wamae; Fred Were; Aggrey Wasunna; Greg Fegan; Norbert Peshu
Journal:  Arch Dis Child       Date:  2008-06       Impact factor: 3.791

5.  The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis.

Authors:  Philip Ayieko; Angela O Akumu; Ulla K Griffiths; Mike English
Journal:  Cost Eff Resour Alloc       Date:  2009-01-22
  5 in total
  1 in total

1.  Cost and cost-effectiveness analysis of treatment for child undernutrition in low- and middle-income countries: A systematic review.

Authors:  Rebecca G Njuguna; James A Berkley; Julie Jemutai
Journal:  Wellcome Open Res       Date:  2020-10-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.